HETERO BIOPHARMA LTD

Company Introduction:

Hetero Biopharma Ltd. is a division of Hetero, one of India's largest generic pharmaceutical companies and a global leader in the production of key active pharmaceutical ingredients (APIs) and finished dosages. Headquartered in Hyderabad, India, Hetero is a vertically integrated pharmaceutical organization with a significant global presence, operating in over 145 countries.

Hetero Biopharma specifically focuses on the research, development, manufacturing, and marketing of biosimilar products. These complex biological drugs are used to treat various conditions such as cancer, autoimmune diseases, and other chronic illnesses. The company places a strong emphasis on research and development (R&D) and operates state-of-the-art manufacturing facilities to produce high-quality, affordable biosimilars, making advanced treatments accessible globally.

Nature of Business:

Hetero Biopharma Ltd. is a manufacturer (factory).

The company owns and operates extensive manufacturing facilities for both active pharmaceutical ingredients (APIs) and finished dosage forms, including dedicated biopharmaceutical manufacturing plants. It is involved in the entire process from research and development to production, quality control, and global distribution of its pharmaceutical and biopharmaceutical products.

Here are some products manufactured or sold by HETERO BIOPHARMA LTD:

Biologics and Biosimilars

Monoclonal Antibodies

Rituximab

Trastuzumab

Bevacizumab

Adalimumab

Denosumab

Ramucirumab

Cetuximab

Nivolumab

Pembrolizumab

Recombinant Proteins

Erythropoietin

Filgrastim

Pegfilgrastim

Interferon alpha-2b

Therapeutic Areas

Oncology

Products for various cancers including breast cancer, colorectal cancer, lymphoma, lung cancer, and others.

Autoimmune Diseases

Products for conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel disease.

Nephrology

Products for chronic kidney disease and related complications.

Hematology

Products for blood disorders and supportive care.

Infectious Diseases

Specific therapeutic agents.

This list represents a range of their biopharmaceutical offerings, primarily focusing on complex biologics and biosimilars.